Racial disparities in drug trials, and disparities in overall medical care, among other factors, make the recently-approved Alzheimer’s break-through drug lecanemab less likely to benefit African Americans.
No comments yet!
Neurodegenative Disease Support
!neurodegdissupport@lemmy.world
This community is a gathering place for all those affected by neurodegenerative diseases. Patients, family, friends and caregivers are welcome. Share info, ask questions, or vent about your day. Whatever you’d like to talk about, we’re here to listen.
COMMUNITY RULES
We follow the Mastodon Code of Conduct in this community.
Please be kind and supportive as you interact with others.
Do not ask for or offer medical advice. This is a community for support and encouragement only.
PARTNERED COMMUNITIES
Community stats
1
Monthly active users
19
Posts
0
Comments